(Q51388945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20955358%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Anti-inflammatory and monocyte-suppressing effects of simvastatin in patients with impaired fasting glucose (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20955358%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20955358%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1

Robert Krysiak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20955358%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

2

Anna Gdula-Dymek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20955358%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Joanna Scieszka

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20955358%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

18 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20955358%20AND%20SRC:MED&resulttype=core&format=json

Basic and Clinical Pharmacology and Toxicology

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20955358%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20955358%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20955358%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

131-137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20955358%20AND%20SRC:MED&resulttype=core&format=json

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Pleiotropic effects of statins--clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Statins: beneficial or adverse for glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Pathobiology of atherosclerosis--a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Cytokines in atherosclerosis: pathogenic and regulatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Inflammatory biomarkers in stable atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Effect of monthly atorvastatin and fenofibrate treatment on monocyte chemoattractant protein-1 release in patients with primary mixed dyslipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Inflammatory mechanisms in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Macrophages: promising targets for the treatment of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Perspectives on low-density lipoprotein cholesterol goal achievement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X

Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2010.00633.X